NagaCorp Ltd. (NGCRF)
USD 0.44
(-2.22%)
USD 0.44
(-2.22%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 257.31 Million | 306.53 Million | 35.95 Million | 213.11 Million | 690.21 Million | 476.68 Million |
| Net Income | 178.14 Million | 107.46 Million | -140.74 Million | 132.13 Million | 551.64 Million | 399.39 Million |
| Depreciation & Amortization | 96.88 Million | 113.69 Million | 119.17 Million | 99.86 Million | 99.84 Million | 92.98 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -529.23 Thousand | 68.63 Million | 22.62 Million | -24.41 Million | 49.7 Million | -26.74 Million |
| Other non-cash items | 169.11 Million | 16.74 Million | 34.9 Million | 5.52 Million | -10.97 Million | 11.05 Million |
| Investing Cash Flow | -48.16 Million | -124.43 Million | -145.24 Million | -118.69 Million | -424.1 Million | -316.9 Million |
| Investments in PPE | -54.99 Million | -128.2 Million | -150.24 Million | -161.82 Million | -450.98 Million | -243.27 Million |
| Acquisitions | 5.9 Million | 52.12 Thousand | 12.95 Million | 3.54 Million | 50.27 Thousand | 5005.23 |
| Investment purchases | -17.03 Thousand | -3.2 Million | -8.06 Million | -3.54 Million | 10.44 Million | -76.44 Million |
| Sales/Maturities of investments | 947.21 Thousand | 3.15 Million | -4.89 Million | 39.09 Million | 23.08 Million | - |
| Other Investing Activities | 928 Thousand | 3.77 Million | 5 Million | 4.03 Million | -6.7 Million | 2.81 Million |
| Financing Cash Flow | -16.33 Million | -128.82 Million | -225.73 Million | 69.94 Million | -309.27 Million | 103.96 Million |
| Debt repayment | -16.29 Million | -73 Million | -300 Million | -335.4 Million | -7.86 Million | -289.13 Million |
| Dividends payments | - | - | -81.4 Million | -233.37 Million | -274.85 Million | -170.81 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -37.53 Million | -55.82 Million | 155.94 Million | 638.66 Million | -28.08 Million | 274.77 Million |
| Accounts receivables | 3.64 Million | 22.7 Million | 50.86 Million | 4.64 Million | -14.45 Million | -17.94 Million |
| Accounts payables | 3.27 Million | 54.56 Million | -21.07 Million | -21.07 Million | 74.01 Million | 186.19 Thousand |
| Inventory | 554.29 Thousand | -1.1 Million | 191 Thousand | 783 Thousand | -716 Thousand | -256 Thousand |
| Other working capital | -8 Million | -7.53 Million | -7.35 Million | -8.77 Million | -9.13 Million | -26.48 Million |
| Cash at beginning of period | 174.61 Million | 102.72 Million | 437.74 Million | 273.37 Million | 316.53 Million | 52.79 Million |
| Cash at end of period | 222.38 Million | 156 Million | 102.72 Million | 437.74 Million | 273.37 Million | 316.53 Million |
| Capital Expenditure | -54.99 Million | -128.2 Million | -150.24 Million | -161.82 Million | -450.98 Million | -243.27 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 47.77 Million | 53.28 Million | -335.01 Million | 164.36 Million | -43.15 Million | 263.74 Million |
| Free Cash Flow | 202.32 Million | 178.33 Million | -114.29 Million | 51.28 Million | 239.23 Million | 233.4 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -481.5 Thousand | -481.5 Thousand | 178.14 Million | 47.37 Million | 47.37 Million | 82.97 Million |
| Depreciation & Amortization | 23.09 Million | 23.09 Million | 96.88 Million | 23.71 Million | 23.71 Million | 49.23 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | -529.23 Thousand | 2.09 Million | 2.09 Million | - |
| Other non-cash items | 62.98 Million | 62.98 Million | 169.11 Million | 4.36 Million | 4.36 Million | 85.6 Million |
| Investing Cash Flow | -243.62 Million | -243.62 Million | -48.16 Million | -11.17 Million | -11.17 Million | -24.66 Million |
| Investments in PPE | -13.18 Million | -13.18 Million | -54.99 Million | -14.63 Million | -14.63 Million | -25.59 Million |
| Acquisitions | 5.1 Million | - | 5.9 Million | 5.88 Million | - | 5999.90 |
| Investment purchases | -472.39 Million | - | -17.03 Thousand | 42.33 | - | -16.99 Thousand |
| Sales/Maturities of investments | - | - | 947.21 Thousand | 946.03 Thousand | - | -0.90 |
| Other Investing Activities | -230.44 Million | -230.44 Million | 928 Thousand | 3.45 Million | 3.45 Million | 944.98 Thousand |
| Financing Cash Flow | 23.67 Million | 23.67 Million | -16.33 Million | -13.22 Million | -13.22 Million | -8.6 Million |
| Debt repayment | -70.07 Million | - | -16.29 Million | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 23.67 Million | 23.67 Million | -37.53 Million | -13.22 Million | -13.22 Million | -13.68 Million |
| Accounts receivables | - | - | 3.64 Million | 1.81 Million | 1.81 Million | - |
| Accounts payables | - | - | 3.27 Million | - | - | - |
| Inventory | - | - | 554.29 Thousand | 276.5 Thousand | 276.5 Thousand | - |
| Other working capital | - | - | -8 Million | - | - | - |
| Cash at beginning of period | 222.38 Million | - | 174.61 Million | 261.22 Million | - | 174.61 Million |
| Cash at end of period | 570.53 Million | -134.35 Million | 222.38 Million | 222.38 Million | 53.14 Million | 261.22 Million |
| Capital Expenditure | -13.18 Million | -13.18 Million | -54.99 Million | -14.63 Million | -14.63 Million | -25.59 Million |
| Effect of forex changes on cash | - | - | - | - | - | 531.22 Thousand |
| Net cash flow / Change in cash | 348.14 Million | -134.35 Million | 47.77 Million | -38.83 Million | 53.14 Million | 86.6 Million |
| Free Cash Flow | 72.41 Million | 72.41 Million | 202.32 Million | 62.92 Million | 62.92 Million | 93.74 Million |
ACCYY
ALAIR
ICFI
CURN
002627
AYR-A